All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 27, 2021
Home » Blogs » BioWorld MedTech Perspectives » Elekta provides LINC to innovation

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Elekta provides LINC to innovation

Nov. 11, 2013
By Omar Ford
No Comments

The first thing that hits you when you walk in Elekta's Learning and Innovation Center (LINC) located in Atlanta, is that there is a lot of history here.

Elekta3

From the Leksell Stereotactic System invented in 1949, to the Leskell Gamma Knife Perfexion - the advances in med-tech through the lens of a once small but now sizeable company are evident.

But to merely think of this as a repository of the firm's greatest technological achievements and advancements in the treatment of cancer would be egregiously wrong. LINC is a learning center that links the past to future innovation.

DSCN0013The 25,000 square foot facility that boasts lecture rooms and all of the firm's latest technology is instead a learning destination. LINC was launched during the American Society for Radiology (Fairfax, Virginia) meeting held in Atlanta in September. Last month, Medical Device Daily toured the facility, which boasts some of the companies flagship technology, such as the new Versa HD linear accelerator and Leksell Gamma Knife Perfexion. Enhancing the experience, students have access to the Versa HD vault, which is large enough for hands-on learning. Elektaphoto1

"Elekta's really putting forward education and training for patient safety as a first priority," Ian Dickson, Elekta's CFO, told Medical Device Daily. "The company has grown so rapidly in the last four or five years – there's been a lot of organic growth but also through acquisition. Our education programs are pretty dispersed around the U.S. so we saw this to really get the value proposition and to put safe training and education on the map for us as an organization into the radiation community we needed to centralize it, and that's what we did by bringing it here into the Perimeter area here in Atlanta."

Elekta4Simply put, Elekta is on the right path to innovation. You can't go forward without investing in the future of your technology.  Giving healthcare professionals the advanced training that they might need on Elekta's wide array of products accomplishes that goal.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Seniors with wooden puzzle

    Cassava’s simufilam improves AD patients’ cognition, behavior

    BioWorld
    When Cassava Sciences Inc.’s president and CEO, Remi Barbier, opened up the interim analysis of the company’s open-label study for Alzheimer’s disease candidate...
  • Vaxart COVID-19 vaccine tablets

    Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine

    BioWorld
    Vaxart Inc. investors who stuck by company shares Feb. 3 had to swallow a bitter pill – watching shares of the oral vaccine developer (NASDAQ:VXRT) fall 57.8% to...
  • IPO money

    Lucira Health launches $153M IPO

    BioWorld MedTech
    Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 26.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing